We’re looking forward to attending BIO-Europe. Will we see you there? If you're attending and are interested in discussing opportunities for co-development of rare disease treatments or out-licensing your drug repurposing assets then we'd be delighted to arrange a time to talk. During the conference you'll be able to meet with the following team members: Dr Mark Youssef, MBA - Global Head of Business Development & Licensing Dr Bruce Bloom - Chief Collaboration Officer Eugenia Wachters, MBA - VP Commercial…

Read more

If you're attending this virtual conference and would like to find out more about the role of AI and drug repurposing in uncovering novel treatments for rare diseases, then please join our Director of Therapeutic Technology, Ian Roberts, PhD, for his presentation 09:00 EST. During the session he will share case study evidence of this AI-powered approach in action and will explore the following areas: How Healx combines AI with drug discovery expertise to find novel treatments for the 95%…

Read more

We’re looking forward to taking part in this upcoming EMBL: EBI industry workshop focused on the latest computational approaches being used in the development of treatments for rare conditions. If you’re attending and would like to learn more about the cutting-edge AI and ML techniques being used to drive forward the discovery and translation of rare disease treatments, we’d recommend joining our Director of Therapeutic Technology, Ian Roberts, PhD, for his presentation on this topic at 17:55 BST. During the…

Read more

Interested in learning more about the role of artificial intelligence in rare disease drug discovery, clinical studies, phenotypic drug discovery, digital biomarkers and more? We recommend attending this BioNJ-hosted briefing session featuring Simone Manso, our Head of Neurofibromatosis Therapy Development. The panel session (09:00-11:00 ET) will be moderated by Daniela Brunner, Ph.D. Chief Innovation Officer of PsychoGenics and will cover many aspects of drug discovery including: AI-powered, patient-inspired treatments for rare diseases - Simone Manso, Head of Neurofibromatosis Therapy Development…

Read more

Findacure’s annual conference highlights the best examples of repurposing and redevelopment in the field of rare diseases - and we’re looking forward to being a part of it as Findacure’s 2021 corporate partner. This conference will see us host an interactive workshop on the role of drug redevelopment in finding potential treatments for your rare disease of interest. During the session we’ll explore the following topics: How to decide early on what your endpoint is to understand and manage your…

Read more

Better understand the technological and commercial/regulatory aspects of drug repurposing at UCLs upcoming webinar series. Our Machine Learning Scientist, Saatviga Sudhahar, will be speaking about how we use AI to uncover new therapeutic uses for known drugs. Here's the full agenda:  Data Driven Approaches to Identify Drug Candidates - Gemma Holliday, Bioinformatics Data Scientist at MDC A Combined In-Silico Drug Repurposing Study - Anna Pallo, Cheminformatician - MDC Machine Learning/AI Solutions Developed at the MDC for Repurposing and Cheminformatics -…

Read more